Literature DB >> 21439648

Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results.

Rudolf Uher1, Avshalom Caspi, Renate Houts, Karen Sugden, Benjamin Williams, Richie Poulton, Terrie E Moffitt.   

Abstract

BACKGROUND: Genetic and environmental factors shape life-long vulnerability to depression, but most gene-environment interaction (G×E) research has focused on cross-sectional assessments rather than life-course phenotypes. This study tests the hypothesis that the G×E involving the length polymorphism in the serotonin-transporter-gene-linked-promoter-region (5-HTTLPR) and childhood maltreatment is specific to depression that runs a persistent course in adulthood.
METHODS: The hypothesis is tested in two cohorts. Men and women in the Dunedin Study (N=847), New Zealand, followed to age 32 years with 96% retention and women in the E-Risk Study (N=930), England, followed to age 40 years with 96% retention. Diagnoses of past-year major depressive episode were established at four separate assessments. Depression diagnosed on two or more occasions was considered persistent.
RESULTS: In both cohorts, statistical tests of gene-environment interactions showed positive results for persistent depression but not single-episode depression. Individuals with two short 5-HTTLPR alleles and childhood maltreatment had elevated risk of persistent but not single-episode depression. LIMITATIONS: Some cases of recurrent depression may have been misclassified as single-episode due to non-contiguous assessment windows, but this would have a conservative effect on the findings. Chronic and recurrent depression could not be reliably distinguished due to non-contiguous periods of assessment. Therefore, the term persistent depression is used to describe either chronic or recurrent course.
CONCLUSIONS: The specific effect on persistent depression increases the significance of this G×E for public health. Research that does not distinguish persistent course may underestimate G×E effects and account for some replication failures in G×E research.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439648      PMCID: PMC3752793          DOI: 10.1016/j.jad.2011.03.010

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  56 in total

1.  Stability of retrospective reports in depression: traumatic events, past depressive episodes, and parental psychopathology.

Authors:  Pamela K Schraedley; R Jay Turner; Ian H Gotlib
Journal:  J Health Soc Behav       Date:  2002-09

Review 2.  Modern approaches to conceptualizing and measuring human life stress.

Authors:  Scott M Monroe
Journal:  Annu Rev Clin Psychol       Date:  2008       Impact factor: 18.561

3.  The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update.

Authors:  R Uher; P McGuffin
Journal:  Mol Psychiatry       Date:  2010-01       Impact factor: 15.992

4.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-17       Impact factor: 79.321

5.  Measuring child maltreatment in the United Kingdom: a study of the prevalence of child abuse and neglect.

Authors:  Corinne May-Chahal; Pat Cawson
Journal:  Child Abuse Negl       Date:  2005-09

6.  Teen-aged mothers in contemporary Britain.

Authors:  Terrie E Moffitt
Journal:  J Child Psychol Psychiatry       Date:  2002-09       Impact factor: 8.982

7.  Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population.

Authors:  M Aguilera; B Arias; M Wichers; N Barrantes-Vidal; J Moya; H Villa; J van Os; M I Ibáñez; M A Ruipérez; G Ortet; L Fañanás
Journal:  Psychol Med       Date:  2009-02-12       Impact factor: 7.723

Review 8.  Finding the missing heritability of complex diseases.

Authors:  Teri A Manolio; Francis S Collins; Nancy J Cox; David B Goldstein; Lucia A Hindorff; David J Hunter; Mark I McCarthy; Erin M Ramos; Lon R Cardon; Aravinda Chakravarti; Judy H Cho; Alan E Guttmacher; Augustine Kong; Leonid Kruglyak; Elaine Mardis; Charles N Rotimi; Montgomery Slatkin; David Valle; Alice S Whittemore; Michael Boehnke; Andrew G Clark; Evan E Eichler; Greg Gibson; Jonathan L Haines; Trudy F C Mackay; Steven A McCarroll; Peter M Visscher
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

9.  Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder.

Authors:  Paul G Surtees; Nicholas W J Wainwright; Saffron A G Willis-Owen; Robert Luben; Nicholas E Day; Jonathan Flint
Journal:  Biol Psychiatry       Date:  2005-09-09       Impact factor: 13.382

10.  Individual, family, and neighborhood factors distinguish resilient from non-resilient maltreated children: a cumulative stressors model.

Authors:  Sara R Jaffee; Avshalom Caspi; Terrie E Moffitt; Monica Polo-Tomás; Alan Taylor
Journal:  Child Abuse Negl       Date:  2007-03-28
View more
  40 in total

Review 1.  Gene-environment interaction in major depression and antidepressant treatment response.

Authors:  Robert Keers; Rudolf Uher
Journal:  Curr Psychiatry Rep       Date:  2012-04       Impact factor: 5.285

2.  Association between the serotonin transporter triallelic genotype and eating problems is moderated by the experience of childhood trauma in women.

Authors:  Scott F Stoltenberg; Cynthia Anderson; Parthasarathi Nag; Cheryl Anagnopoulos
Journal:  Int J Eat Disord       Date:  2012-01-23       Impact factor: 4.861

Review 3.  Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm

Authors:  Paul R. Albert; Brice Le François; Faranak Vahid-Ansari
Journal:  J Psychiatry Neurosci       Date:  2019-05-01       Impact factor: 6.186

4.  Vulnerability to depression: a moderated mediation model of the roles of child maltreatment, peer victimization, and serotonin transporter linked polymorphic region genetic variation among children from low socioeconomic status backgrounds.

Authors:  Adrienne M Banny; Dante Cicchetti; Fred A Rogosch; Assaf Oshri; Nicki R Crick
Journal:  Dev Psychopathol       Date:  2013-08

5.  The interaction between stress and genetic factors in the etiopathogenesis of depression.

Authors:  Peter McGuffin; Margarita Rivera
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

6.  Genetic variants in 5-HTTLPR, BDNF, HTR1A, COMT, and FKBP5 and risk for treated depression after cancer diagnosis.

Authors:  Nis P Suppli; Jens D Bukh; Terrie E Moffitt; Avshalom Caspi; Christoffer Johansen; Anne Tjønneland; Lars V Kessing; Susanne O Dalton
Journal:  Depress Anxiety       Date:  2017-06-07       Impact factor: 6.505

7.  Genetic moderation of the association between adolescent romantic involvement and depression: Contributions of serotonin transporter gene polymorphism, chronic stress, and family discord.

Authors:  Lisa R Starr; Constance Hammen
Journal:  Dev Psychopathol       Date:  2015-06-03

8.  Harsh Parenting and Serotonin Transporter and BDNF Val66Met Polymorphisms as Predictors of Adolescent Depressive Symptoms.

Authors:  Kalsea J Koss; E Mark Cummings; Patrick T Davies; Susan Hetzel; Dante Cicchetti
Journal:  J Clin Child Adolesc Psychol       Date:  2016-10-13

9.  Gene-environment interactions in common mental disorders: an update and strategy for a genome-wide search.

Authors:  Rudolf Uher
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-12-10       Impact factor: 4.328

10.  Interaction between specific forms of childhood maltreatment and the serotonin transporter gene (5-HTT) in recurrent depressive disorder.

Authors:  Helen L Fisher; Sarah Cohen-Woods; Georgina M Hosang; Ania Korszun; Mike Owen; Nick Craddock; Ian W Craig; Anne E Farmer; Peter McGuffin; Rudolf Uher
Journal:  J Affect Disord       Date:  2012-07-25       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.